Johnson and Johnson Vision Announces TearScience LipiScan(R) and LipiFlow(R) Now Available in More Than 800 Eye Care Practices to Image Meibomian Glands and Treat Meibomian Gland Dysfunction

Meibomian Gland Dysfunction (MGD) is a primary cause of dry eye disease, which impacts more than 340 million people globally LipiScan® and LipiFlow® technologies offer rapid, effective solutions for optometry and ophthalmology practices in North... Devices, Ophthalmology, Product Launch Johnson & Johnson, TearScience, LipiScan, LipiFlow, Meibomian Gland, dry eye
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news